Latest News

Cellectis (NASDAQ:CLLS) outlined plans to advance two preclinical in vivo gene-editing candidates for severe forms of dyslipidemia, targeting hypertriglyceridemia and hypercholesterolemia through one-time intravenous treatments. Chief Executive Officer André Choulika said the company is building on

Staying invested during a bear market is tough, but history shows it's worth riding out the volatility to build wealth.

Skyworks is preparing for one of the biggest changes in its history. The numbers behind the Qorvo deal reveal what could drive the next phase and what could derail it.

Amphenol is trading near an all-time high. Does a maker of connectors and cables still have room to run?

The TSX is up this year, but you can take advantage of recent pullbacks by swiping up these four high quality Canadian stocks.

SK Hynix's revenue has accelerated dramatically over eight quarters, while ASML maintained steadier growth — a divergence that reshapes how investors should view these semiconductor-industry heavyweights.

Buybacks can signal that a company's best growth days are behind it, but that isn't the case with Nvidia.

Your 2026 TFSA dollar limit may be $7,000, but your actual room can be very different.

AMD grew far faster than Applied Materials in 2025, but its stock carries a richer valuation and potential dilution from warrants issued to two large AI customers.

Schwab's lower costs and higher dividend yield appeal to income investors, while Vanguard's broader global reach suits those seeking complete market exposure.

The difference between its lump sum and monthly compound returns is jarring.

ASML offers unmatched demand visibility, while Applied Materials brings broader AI-driven growth at a lower valuation.

Vertex dominates cystic fibrosis with expanding disease coverage and a pipeline entering new therapeutic areas. Axsome is building a commercial drug portfolio quickly but is still working toward consistent profitability.

Johnson & Johnson's revenue base runs roughly double Bristol-Myers Squibb's, with the gap showing signs of widening over the past two years.

Honeywell Aerospace is the obvious beneficiary, but is it the really the best choice?

NextEra Energy (NYSE:NEE) CEO John Ketchum said the company has made significant progress on its growth plan in recent months, including securing federal hub opportunities, expanding gas and storage development prospects and advancing a proposed combination involving Dominion operations in Virginia,

One designs the chips, while the other manufactures the machines that build them. But their valuations tell a starkly different story.

Palantir stock has made a parabolic move, and it could surge higher amid growing demand for AI software.

Nvidia has delivered a win to investors in recent years.

Accenture just beat on earnings, but why is Infosys stock up, too?

Arm compounds reliably across billions of devices. Credo is posting near-triple-digit growth in AI data center connectivity. The growth gap is significant, and so is the valuation gap.

The small modular reactor maker faces plenty of near-term headwinds.

Warren Buffett's tenure as chairman of the board was fairly short, but he already had a succession plan in place.

Broadcom has locked-in AI revenue commitments from the world's largest tech companies, while Applied Materials offers broad chip equipment exposure across the semiconductor manufacturing build-out.

Space stocks are heating up as the U.S. and China race to build a base on the Moon. Here are three to watch, from a high-upside lander to a steady defense supplier.